What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Enzyme
Her primary scientific interests are in Internal medicine, Plasminogen activator, Endocrinology, Immunology and Fibrinolysis.
Her biological study spans a wide range of topics, including Gastroenterology and Cardiology.
Her studies in Plasminogen activator integrate themes in fields like Molecular biology, Tissue plasminogen activator, Activator and Urokinase.
Her studies deal with areas such as Vascular endothelial growth factor A, Vascular endothelial growth factor and Angiogenesis as well as Endocrinology.
Desire Collen combines subjects such as Placental growth factor, Endothelium and Cell biology with her study of Angiogenesis.
Her Fibrinolysis research is multidisciplinary, relying on both Plasminogen Inactivators, Staphylokinase, Plasmin and Fibrin.
Her most cited work include:
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele (3700 citations)
- Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. (2107 citations)
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (1431 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Internal medicine, Plasminogen activator, Molecular biology, Endocrinology and Biochemistry.
Her Internal medicine study frequently links to other fields, such as Cardiology.
Her Plasminogen activator study combines topics from a wide range of disciplines, such as Plasmin, Urokinase, Thrombolysis, Fibrinolysis and Tissue plasminogen activator.
Her Fibrinolysis research is multidisciplinary, incorporating perspectives in Immunology and Fibrin.
Her Molecular biology research includes elements of Monoclonal antibody, Plasminogen activator inhibitor-1 and Recombinant DNA.
Desire Collen has included themes like Vascular endothelial growth factor A and Vascular endothelial growth factor in her Angiogenesis study.
She most often published in these fields:
- Internal medicine (31.79%)
- Plasminogen activator (29.98%)
- Molecular biology (20.14%)
What were the highlights of her more recent work (between 2002-2020)?
- Internal medicine (31.79%)
- Endocrinology (16.40%)
- Immunology (13.57%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Endocrinology, Immunology, Cancer research and Cell biology.
Her study connects Cardiology and Internal medicine.
The various areas that Desire Collen examines in her Endocrinology study include Matrix metalloproteinase and In vivo.
Her Immunology study combines topics in areas such as Urokinase receptor, Genetic enhancement and Plasmin.
Her Angiogenesis research is multidisciplinary, incorporating elements of Cancer, Endothelium and Vascular endothelial growth factor.
Her research ties Plasminogen activator and Myocardial infarction together.
Between 2002 and 2020, her most popular works were:
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (768 citations)
- Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (672 citations)
- Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels (668 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Desire Collen mostly deals with Internal medicine, Endocrinology, Immunology, Angiogenesis and Cancer research.
Her research on Internal medicine often connects related topics like Cardiology.
The Endocrinology study combines topics in areas such as Transgene and Heart failure.
Her Immunology research incorporates themes from Metastasis, Genetic enhancement and Coagulation.
Her Angiogenesis research incorporates elements of Vascular endothelial growth factor A, Placental growth factor, Vascular endothelial growth factor and Endothelium.
The Plasminogen activator study which covers Thrombosis that intersects with Clinical trial, Fibrinolysis and Tissue plasminogen activator.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
